ロード中...
Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury
Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2020-11-01
|
| シリーズ: | Cell & Bioscience |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s13578-020-00492-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|